Latest News On Biden Administration

Latest KFF Health News Stories

Evaluating President Joe Biden’s First 100 Days in Office

KFF Health News Original

Presidential historians say that Joe Biden’s first 100 days in office — a somewhat arbitrary but frequently cited milestone — have included an above-average number of major accomplishments.

KHN’s ‘What the Health?’: Picking Up the Pace of Undoing Trump Policies

KFF Health News Original

The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden’s nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Biden Seeks $400 Billion to Buttress Long-Term Care. A Look at What’s at Stake.

KFF Health News Original

Long-term care options are expensive and often out of reach for seniors and people with disabilities. The president has proposed a massive infusion of federal funding for home and community-based health services that advocates say will go a long way toward helping individuals and families.

‘Explained by KHN’: Health Insurance Help in Covid Relief Law

KFF Health News Original

In this edition of “Explained by KHN” Emmarie Huetteman covers how the $1.9 trillion covid relief law will make health insurance coverage significantly more affordable for millions of people.

KHN’s ‘What the Health?’: Health Care as Infrastructure

KFF Health News Original

President Joe Biden’s infrastructure proposal includes items not traditionally considered “infrastructure,” including a $400 billion expansion of home and community-based services for seniors and people with disabilities, and a $50 billion effort to replace water pipes lined with lead. Meanwhile, the politics of covid-19 are turning to how or whether Americans will need to prove they’ve been vaccinated. Joanne Kenen of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KFF’s Mollyann Brodie about the KFF COVID-19 Vaccine Monitor.

KHN’s ‘What the Health?’: Planning for Round Two

KFF Health News Original

The ink is barely dry on the recent covid relief bill, but Democrats in Congress and President Joe Biden are wasting no time gearing up for their next big legislative package. Meanwhile, predictions of more states expanding Medicaid have proved premature. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Lauren Weber, who reported the latest KHN-NPR “Bill of the Month” episode.

Democrats Could Undo Trump Policies Faster, But They’re Not. Why?

KFF Health News Original

The little-used Congressional Review Act allows a new administration and Congress to fast-track the repeal of regulations and other executive actions of the previous administration. But neither lawmakers nor the president are making any attempt to use it now.

Under New Cost-Cutting Medicare Rule, Same Surgery, Same Place, Different Bill

KFF Health News Original

A Trump administration Medicare rule will push some hospital patients into a Catch-22: The government says several hundred procedures no longer need to be done in a hospital, but it did not approve them to be performed elsewhere. So patients will still need to use a hospital while not officially admitted — and may be charged more out-of-pocket for the care.

Democrats Eye Medicare Negotiations to Lower Drug Prices

KFF Health News Original

Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.

The Case for Donating US Covid Vaccines Overseas

KFF Health News Original

For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.

KHN’s ‘What the Health?’: ACA Packs More Benefits — And More Confusion

KFF Health News Original

The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.

Landmark Covid Relief Law Pumps More Than $100 Billion Into Public Health

KFF Health News Original

The law provides money to enhance coronavirus testing and contact tracing, support federal efforts on vaccine distribution and hire more public health workers. But advocates worry support will wane when the pandemic is over.